title: Antiphospholipid syndrome in childhood systemic lupus erythematosus.
abstract: Antiphospholipid syndrome is an autoimmune disease that presents with recurrent arteriovenous thrombosis, repeated pregnancy loss and elevated titres of antiphospholipid antibodies in the blood. It is a common cause of acquired thrombosis and can manifest within any part of the vascular tree. Inferior Venacava thrombosis at outset, however, is not a common manifestation of systemic lupus erythematosus associated-antiphospholipid syndrome particularly in children. Here, we present a 14-year old girl who developed antiphospholipid syndrome as a presenting manifestation of systemic lupus erythematosus.
authors: Department of Medicine, Patan Hospital, Kathmandu, Nepal. buddhipaudyal@yahoo.com
authors: B
authors: B
authors: Paudyal
mesh_terms: D000293:Adolescent; D000959:Antihypertensive Agents / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000453:epidemiology*; D011241:Prednisone / Q000627:therapeutic use; D014682:Vena Cava, Inferior / Q000473:pathology*; D020246:Venous Thrombosis / Q000188:drug therapy / Q000473:pathology*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D005938:Glucocorticoids; D006852:Hydrochlorothiazide; D014859:Warfarin; D006493:Heparin; D011241:Prednisone